In a relatively short time after the discovery of IDH1 mutation in glioblastoma, a tremendous amount of work has been performed on the clinical relevance of this mutation regarding particularly its applications in the diagnosis, prognosis, and treatment of patients suffering from glioblastoma. Here, IDH1 is linked to glioblastoma.